Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...

With a 5.98% market share, India is the fourth-largest pharmaceutical supplier to the U.S., behind Ireland, Switzerland, and ...

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to ...

Patient advocacy groups are urging the South African government to reopen an antitrust investigation into Vertex ...

The talks are a result of the MFN order, which seeks to make US drug prices match lower prices in international markets.

The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market.

The movement’s advocates want him to go further in restricting vaccines and pesticides, despite industry pressure.

Industry experts warn that key Indian export sectors such as textiles, generic drugs, leather, chemicals, footwear, gems and ...

Gilead's PrEP Yeztugo is set to become the pharma's star asset, with GlobalData forecasting of just under $5bn in 2031.

U.S. President Donald Trump imposed an additional 25% tariff on goods imported from India this week, citing New Delhi's ...

As drug companies increasingly adopt the DTC sales model, patients will gain the ability to buy the medicines they need at ...

Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, ...